
Opinion|Videos|January 19, 2024
Key Takeaways for Patients With Myelofibrosis
Author(s)Christine Cooper, RN, BSN, Aaron Gerds, MD, MS
Patients with myelofibrosis should reflect on their personal priorities and quality of life goals, understand the range of available JAK inhibitor treatment options, and openly communicate with their doctor to arrive at a shared decision for managing their disease.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From ASCO 2026 That Patients Should Know
2
Pumitamig Shows 70% Response in Advanced Lung Cancer Regardless of PD-L1 Status
3
Nurse-Led Quality Initiative Reduces CLABSI Risk in Hematologic Cancer Care
4
Medical Cannabis Education Improves Oncology Nurses’ Confidence in Patient Discussions
5
